Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centrient Pharmaceuticals
Rotterdam, Zuid Holland, Netherlandscentrient.com ↗
- Ownership
- Private
- Employees
- ~1800
- Development stage
- Other
01
Overview
Centrient has a long-standing commercial track record in the manufacture of essential generic medicines—primarily antibiotics, statins, and anti-fungals. The company leads in sustainable enzymatic antibiotic production and supplies APIs and finished dosage forms globally. It does not conduct clinical trials as a traditional biotech would; its products are established generics.
- Therapeutic areas
- CardiovascularInfectious Diseases
- Modalities
- Small molecule (antibiotics, statins)Protein (anti-fungals like nystatin)Biologic (enzymatic/fermentation-based production for antibiotics)
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Centrient Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Centrient Pharmaceuticals.